[go: up one dir, main page]

NO984143L - Ny prosess for å fremstille overflatemodifiserende stoffer - Google Patents

Ny prosess for å fremstille overflatemodifiserende stoffer

Info

Publication number
NO984143L
NO984143L NO984143A NO984143A NO984143L NO 984143 L NO984143 L NO 984143L NO 984143 A NO984143 A NO 984143A NO 984143 A NO984143 A NO 984143A NO 984143 L NO984143 L NO 984143L
Authority
NO
Norway
Prior art keywords
new process
surface modifying
producing surface
modifying substances
heparin
Prior art date
Application number
NO984143A
Other languages
English (en)
Other versions
NO984143D0 (no
Inventor
Elisabeth Scholander
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Priority to NO984143A priority Critical patent/NO984143L/no
Publication of NO984143D0 publication Critical patent/NO984143D0/no
Priority to PCT/NO1999/000277 priority patent/WO2000013718A1/en
Priority to ES99944936T priority patent/ES2203177T3/es
Priority to KR1020017002986A priority patent/KR100669132B1/ko
Priority to DK99944936T priority patent/DK1112097T3/da
Priority to DE69909104T priority patent/DE69909104T2/de
Priority to US09/763,873 priority patent/US6461665B1/en
Priority to PT99944936T priority patent/PT1112097E/pt
Priority to AU57652/99A priority patent/AU757913B2/en
Priority to AT99944936T priority patent/ATE243538T1/de
Priority to CA002342991A priority patent/CA2342991C/en
Priority to BRPI9913516-7A priority patent/BR9913516B1/pt
Priority to EP99944936A priority patent/EP1112097B1/en
Priority to JP2000568523A priority patent/JP4152075B2/ja
Publication of NO984143L publication Critical patent/NO984143L/no
Priority to NO20011182A priority patent/NO321029B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører en ny prosess for å fremstille overflatemodifikasjoner med en forbedret antitrombogen virkning og de overflatemodifiserte substratene som dermed blir fremstilt.
NO984143A 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer NO984143L (no)

Priority Applications (15)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer
JP2000568523A JP4152075B2 (ja) 1998-09-09 1999-09-08 表面改質物質を調整する新方法
US09/763,873 US6461665B1 (en) 1998-09-09 1999-09-08 Process for preparing surface modification substances
AU57652/99A AU757913B2 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
KR1020017002986A KR100669132B1 (ko) 1998-09-09 1999-09-08 표면 개질을 생성하는 신규 방법
DK99944936T DK1112097T3 (da) 1998-09-09 1999-09-08 Ny fremgangsmåde til fremstilling af substanser til overflademodificering
DE69909104T DE69909104T2 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
PCT/NO1999/000277 WO2000013718A1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
PT99944936T PT1112097E (pt) 1998-09-09 1999-09-08 Processo novo para preparar substancias de modificacao de superficies
ES99944936T ES2203177T3 (es) 1998-09-09 1999-09-08 Nuevo procedimiento para preparar sustancias de modificacion de superficies.
AT99944936T ATE243538T1 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
CA002342991A CA2342991C (en) 1998-09-09 1999-09-08 Antithrombogenic surfaces comprising immobilized heparin and methods for producing same
BRPI9913516-7A BR9913516B1 (pt) 1998-09-09 1999-09-08 processo para a produção de uma modificação em superfìcie que tem uma atividade não trombogênica melhorada.
EP99944936A EP1112097B1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
NO20011182A NO321029B1 (no) 1998-09-09 2001-03-08 Ny fremgangsmate for a fremskaffe overflatemodifikasjon samt overflatemodifisert substrat.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer

Publications (2)

Publication Number Publication Date
NO984143D0 NO984143D0 (no) 1998-09-09
NO984143L true NO984143L (no) 2000-03-10

Family

ID=19902393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer

Country Status (14)

Country Link
US (1) US6461665B1 (no)
EP (1) EP1112097B1 (no)
JP (1) JP4152075B2 (no)
KR (1) KR100669132B1 (no)
AT (1) ATE243538T1 (no)
AU (1) AU757913B2 (no)
BR (1) BR9913516B1 (no)
CA (1) CA2342991C (no)
DE (1) DE69909104T2 (no)
DK (1) DK1112097T3 (no)
ES (1) ES2203177T3 (no)
NO (1) NO984143L (no)
PT (1) PT1112097E (no)
WO (1) WO2000013718A1 (no)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1112043B1 (en) 1998-09-10 2006-04-05 Percardia, Inc. Tmr shunt
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
JP2002524196A (ja) 1998-09-10 2002-08-06 パーカーディア，インコーポレイティド 左心室血管再生用の経心筋シャントおよびその取付機構
US6290728B1 (en) 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US6409697B2 (en) 1999-05-04 2002-06-25 Heartstent Corporation Transmyocardial implant with forward flow bias
US6638237B1 (en) 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
US7033372B1 (en) 1999-08-04 2006-04-25 Percardia, Inc. Corkscrew reinforced left ventricle to coronary artery channel
SE515295C2 (sv) 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
US6854467B2 (en) 2000-05-04 2005-02-15 Percardia, Inc. Methods and devices for delivering a ventricular stent
US6976990B2 (en) 2001-01-25 2005-12-20 Percardia, Inc. Intravascular ventriculocoronary bypass via a septal passageway
US7008397B2 (en) 2002-02-13 2006-03-07 Percardia, Inc. Cardiac implant and methods
DE60324787D1 (de) * 2002-05-10 2009-01-02 Salviac Ltd System zum filtern von emboli
US7326219B2 (en) 2002-09-09 2008-02-05 Wilk Patent Development Device for placing transmyocardial implant
US6926965B2 (en) * 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
WO2005115490A2 (en) * 2004-05-25 2005-12-08 Surmodics, Inc. Natural biodegradable polysaccharide coatings for meical articles
US20060159650A1 (en) * 2005-01-14 2006-07-20 Bacterin, Inc. Composition and method for covalently coupling an antithrombotic substance and a hydrophilic polymer
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
BRPI0619820A2 (pt) 2005-12-13 2011-10-18 Exthera Ab método de remoção extracorpórea de um micróbio patogênico, uma célula inflamatória ou uma proteìna inflamatória do sangue
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US9114194B2 (en) * 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
JPWO2008032758A1 (ja) 2006-09-15 2010-01-28 東レ株式会社 基材およびその製造方法
US20090281059A1 (en) * 2007-02-21 2009-11-12 Robert Falotico Coating for a medical device having an anti-thrombotic conjugate
US20080200421A1 (en) * 2007-02-21 2008-08-21 Zhao Jonathon Z Coating for a medical device having an anti-thrombotic conjugate
US8114465B2 (en) 2007-04-02 2012-02-14 Ension, Inc. Process for preparing a substrate coated with a biomolecule
US9693841B2 (en) 2007-04-02 2017-07-04 Ension, Inc. Surface treated staples, sutures and dental floss and methods of manufacturing the same
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8383156B2 (en) 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
US8663148B2 (en) * 2007-06-18 2014-03-04 Exthera Medical Corporation Device and method for restoration of the condition of blood
US20090018646A1 (en) 2007-07-10 2009-01-15 Zhao Jonathon Z Coating Employing an Anti-Thrombotic Conjugate
US20090192079A1 (en) * 2007-10-09 2009-07-30 Genzyme Corporation Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
GB0816783D0 (en) * 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
US7819914B2 (en) * 2008-12-16 2010-10-26 Cordis Corporation Adhesion promoting primer for coated surfaces
US20100161039A1 (en) * 2008-12-23 2010-06-24 Vipul Dave Adhesion promoting temporary mask for coated surfaces
AU2010200316A1 (en) * 2009-01-30 2010-08-19 Cordis Corporation Reservoir Eluting Stent
AU2010215191B2 (en) * 2009-02-21 2014-09-04 Sofradim Production Medical device with degradation-retarding coating
EP2398524B1 (en) * 2009-02-21 2017-07-12 Covidien LP Medical devices having activated surfaces
US8658707B2 (en) 2009-03-24 2014-02-25 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expanded functional products obtained therefrom and reaction of the expanded products
US9139669B2 (en) 2009-03-24 2015-09-22 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expandable functional products obtained therefrom and reaction of the expanded products
US8591932B2 (en) 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
CA2967094C (en) 2009-12-01 2022-08-16 Exthera Medical Corporation Method for removing cytokines from blood with surface immobilized polysaccharides
EP2518100B1 (en) 2009-12-24 2015-02-18 Toray Industries, Inc. Hydrophilic polymer compound having anticoagulation effect
GB201004101D0 (en) * 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
BR112012029896A2 (pt) 2010-05-25 2017-06-20 Jenavalve Tech Inc válcula cardíaca protética para endoprótese e endoprótese
US9839540B2 (en) 2011-01-14 2017-12-12 W. L. Gore & Associates, Inc. Stent
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US9415193B2 (en) 2011-03-04 2016-08-16 W. L. Gore & Associates, Inc. Eluting medical devices
US20120310210A1 (en) 2011-03-04 2012-12-06 Campbell Carey V Eluting medical devices
KR101933237B1 (ko) 2011-03-11 2018-12-27 더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 고정화된 생물학적 실체의 개선
TW201311774A (zh) 2011-06-23 2013-03-16 Toray Industries 具有抗血液凝固作用的疏水性高分子化合物
TW201309354A (zh) 2011-06-23 2013-03-01 Toray Industries 醫療材料
US9775933B2 (en) 2012-03-02 2017-10-03 W. L. Gore & Associates, Inc. Biocompatible surfaces and devices incorporating such surfaces
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US10376360B2 (en) 2012-07-27 2019-08-13 W. L. Gore & Associates, Inc. Multi-frame prosthetic valve apparatus and methods
US9931193B2 (en) 2012-11-13 2018-04-03 W. L. Gore & Associates, Inc. Elastic stent graft
US9737398B2 (en) 2012-12-19 2017-08-22 W. L. Gore & Associates, Inc. Prosthetic valves, frames and leaflets and methods thereof
US10966820B2 (en) 2012-12-19 2021-04-06 W. L. Gore & Associates, Inc. Geometric control of bending character in prosthetic heart valve leaflets
US10321986B2 (en) 2012-12-19 2019-06-18 W. L. Gore & Associates, Inc. Multi-frame prosthetic heart valve
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
HK1216625A1 (zh) 2013-06-24 2016-11-25 Exthera Medical Corporation 含有塗覆甘露糖的基質的血液過濾系統
US9867694B2 (en) 2013-08-30 2018-01-16 Jenavalve Technology Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
WO2015069942A1 (en) 2013-11-08 2015-05-14 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
AU2014355413B2 (en) 2013-11-28 2017-06-22 Toray Industries, Inc. Anti-thrombotic material
US9795721B2 (en) 2013-11-28 2017-10-24 Toray Industries, Inc. Antithrombotic material
US10842918B2 (en) 2013-12-05 2020-11-24 W.L. Gore & Associates, Inc. Length extensible implantable device and methods for making such devices
US10251742B2 (en) 2014-02-12 2019-04-09 Toray Industries, Inc. Artificial blood vessel
US11839698B2 (en) 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
JP2017513636A (ja) 2014-04-24 2017-06-01 エクスセラ メディカル コーポレイション 高流量を用いて血液から細菌を除去するための方法
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
JP7100454B2 (ja) 2014-09-22 2022-07-13 エクスセラ メディカル コーポレイション 装着型血液潅流デバイス
JP6829692B2 (ja) 2015-03-20 2021-02-10 イェーナヴァルヴ テクノロジー インコーポレイテッド 心臓弁プロテーゼ送出システム及び導入体シースにより心臓弁プロテーゼを送出するための方法
JP6767388B2 (ja) 2015-05-01 2020-10-14 イェーナヴァルヴ テクノロジー インコーポレイテッド 心臓弁置換におけるペースメーカー割合を低減させるデバイス及び方法
EP3095509A1 (en) 2015-05-18 2016-11-23 Defymed Membranes functionalized with heparin for bioartificial organs
US10561766B2 (en) 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
CA3021860C (en) 2016-04-21 2021-06-08 W. L. Gore & Associates, Inc. Diametrically adjustable endoprostheses and associated systems and methods
CN109475419B (zh) 2016-05-13 2021-11-09 耶拿阀门科技股份有限公司 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法
WO2018061916A1 (ja) 2016-09-30 2018-04-05 東レ株式会社 共重合体及びこれを用いた医療材料
AU2017340701A1 (en) 2016-10-07 2019-04-04 Toray Industries, Inc. Tubular woven fabric
EP3318294A1 (en) 2016-11-08 2018-05-09 Defymed Kit for in situ delivery of a compound of interest
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
KR20190130618A (ko) 2017-03-31 2019-11-22 도레이 카부시키가이샤 통 형상 구조체
JP6974601B2 (ja) 2017-09-12 2021-12-01 ダブリュ.エル.ゴア アンド アソシエイツ, インコーポレイティドW.L. Gore & Associates, Incorporated 人工弁のためのリーフレットフレーム取り付け装置
CN111163728B (zh) 2017-09-27 2022-04-29 W.L.戈尔及同仁股份有限公司 具有机械联接的瓣叶的假体瓣膜
WO2019067219A1 (en) 2017-09-27 2019-04-04 W. L. Gore & Associates, Inc. PROSTHETIC VALVE WITH EXTENSIBLE FRAME AND ASSOCIATED SYSTEMS AND METHODS
AU2018348022B2 (en) 2017-10-09 2021-07-08 W. L. Gore & Associates, Inc. Matched stent cover
US11090153B2 (en) 2017-10-13 2021-08-17 W. L. Gore & Associates, Inc. Telescoping prosthetic valve and delivery system
JP7227240B2 (ja) 2017-10-31 2023-02-21 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 人工心臓弁
EP3703615B1 (en) 2017-10-31 2024-05-15 W. L. Gore & Associates, Inc. Transcatheter deployment systems and associated methods
CA3078606C (en) 2017-10-31 2023-09-05 W.L. Gore & Associates, Inc. Medical valve and leaflet promoting tissue ingrowth
CA3086692A1 (en) 2018-01-30 2019-08-08 Toray Industries, Inc. Plain-weave fabric, method for manufacturing same, and stent graft
WO2019170859A2 (en) 2018-03-09 2019-09-12 Carmeda Ab Improvements to immobilising biological entities
WO2019170858A1 (en) 2018-03-09 2019-09-12 Carmeda Ab Improvements to processes for immobilising biological entities
AU2019306239B2 (en) 2018-07-18 2022-08-25 W. L. Gore & Associates, Inc. Implantable medical device deployment system
JP7584404B2 (ja) 2018-10-03 2024-11-15 カルメダ エービー 固定化された生物学的実体
US20200179663A1 (en) 2018-12-11 2020-06-11 W. L. Gore & Associates, Inc. Medical devices for shunts, occluders, fenestrations and related systems and methods
US11911135B2 (en) 2018-12-21 2024-02-27 W. L. Gore & Associates, Inc. Implantable medical device with adjustable blood flow
CN113330151A (zh) 2019-01-30 2021-08-31 东丽株式会社 心血管留置装置用的医疗基材
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
EP3952790A1 (en) 2019-04-12 2022-02-16 W.L. Gore & Associates, Inc. Valve with multi-part frame and associated resilient bridging features
BR112021021141A2 (pt) 2019-05-16 2021-12-14 Exthera Medical Corp Método para modular estrutura glicocalyx endotelial
US20220401105A1 (en) 2019-11-15 2022-12-22 W. L. Gore & Associates, Inc. Left atrial appendage device and methods
JP2023511320A (ja) 2020-01-17 2023-03-17 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド ２つのフレーム構成要素及びアイレット対を含むメディカルインプラント
US20230338727A1 (en) 2020-02-04 2023-10-26 W. L. Gore & Associates, Inc. Inflow / outflow cannula
WO2021204935A1 (en) 2020-04-09 2021-10-14 Defymed Membranes for medical devices
EP3892259A1 (en) 2020-04-09 2021-10-13 Defymed Membranes for medical devices
US12171658B2 (en) 2022-11-09 2024-12-24 Jenavalve Technology, Inc. Catheter system for sequential deployment of an expandable implant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4600652A (en) 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
US5049403A (en) * 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
IT1260136B (it) 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
US5679659A (en) * 1995-08-22 1997-10-21 Medtronic, Inc. Method for making heparinized biomaterials
US6174326B1 (en) 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production

Also Published As

Publication number Publication date
ATE243538T1 (de) 2003-07-15
DK1112097T3 (da) 2003-10-20
DE69909104T2 (de) 2004-04-08
US6461665B1 (en) 2002-10-08
CA2342991C (en) 2009-01-27
PT1112097E (pt) 2003-11-28
AU5765299A (en) 2000-03-27
JP4152075B2 (ja) 2008-09-17
BR9913516B1 (pt) 2010-09-21
AU757913B2 (en) 2003-03-13
CA2342991A1 (en) 2000-03-16
BR9913516A (pt) 2001-06-05
KR20010088799A (ko) 2001-09-28
WO2000013718A1 (en) 2000-03-16
EP1112097A1 (en) 2001-07-04
ES2203177T3 (es) 2004-04-01
DE69909104D1 (de) 2003-07-31
NO984143D0 (no) 1998-09-09
JP2003507082A (ja) 2003-02-25
KR100669132B1 (ko) 2007-01-17
EP1112097B1 (en) 2003-06-25

Similar Documents

Publication Publication Date Title
NO984143L (no) Ny prosess for å fremstille overflatemodifiserende stoffer
NO872602D0 (no) Elektrisk kontaktsett, saerlig for bruk under vann.
ES536909A0 (es) Procedimiento para la preparacion de compuestos complejos de piroxicam con ciclodestrinas
DE68902916D1 (de) Herstellung von quecksilberfreiem synthesegas, reduktionsgas oder brenngas.
DE69823361D1 (de) Herstellung von kollagen
EA200000473A1 (ru) Состав модифицированного крахмала для удаления частиц из водных дисперсий
ID26310A (id) Produksi kontinyu 1,3-dioksolan-2-ona
EA200000351A1 (ru) Лечение кондуктивных нарушений
MX9701397A (es) Emulsiones topicas de ketoconazol.
DE69502154D1 (de) Herstellung von cis-1,4-Polybutadien mit verminderter Gelbildung
NO961604L (no) Ketogruppe-introduserende enzym, DNA som koder for samme, samt fremgangsmåte for fremstilling av ketokarotenoid
EA199800152A1 (ru) Лечение синдрома дефицита внимания/гиперактивности
CA2324887A1 (fr) Composition ophtalmique comprenant un .beta.-bloquant
FI963749A0 (fi) Huokoinen metallikomposiittikappale
DE60002103D1 (de) Stabilisierung von blutplättchen
ATE237568T1 (de) Neue substanzbibliothek und damit hergestellte supramolekulare komplexe
MY119876A (en) A method of dewatering organic liquids
NO20003151L (no) Kationisk tverrbundet stivelse med stabil og "skreddersydd" viskositet
DE3886225D1 (de) Pyruvat-Oxidase, ihre Herstellung und Verwendung.
IT1216721B (it) Procedimento per la produzione di bricchette di combustibile senza fumo trattate.
DE69421195D1 (de) Einstufige herstellung von 4,6 dinitroresorcinol aus resorcinol
KR910008138A (ko) 효소법에 의한 l-세린의 제조법
DE69729114D1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung
CA2195498A1 (en) Modification of Starch
GB9818650D0 (en) Therapeutic compounds and methods of making and using the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application